Provided by Tiger Trade Technology Pte. Ltd.

Nektar Therapeutics

45.77
-1.2241-2.61%
Volume:471.04K
Turnover:21.76M
Market Cap:1.56B
PE:-7.08
High:47.13
Open:47.11
Low:45.69
Close:46.99
52wk High:109.00
52wk Low:33.40
Shares:34.14M
Float Shares:28.53M
Volume Ratio:1.41
T/O Rate:1.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.4680
EPS(LYR):-9.7254
ROE:-35.75%
ROA:-12.54%
PB:1.73
PE(LYR):-4.71

Loading ...

Aug 05, 2021

Major Issues Report

8-K - Current report
Jun 15, 2021

Major Issues Report

8-K - Current report
May 07, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2021

Major Issues Report

8-K - Current report
Feb 26, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 25, 2021

Major Issues Report

8-K - Current report
Feb 17, 2021

Major Issues Report

8-K - Current report
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 04, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 27, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 11, 2021

Major Issues Report

8-K - Current report
Jan 05, 2021

Major Issues Report

8-K - Current report
Dec 22, 2020

Major Issues Report

8-K - Current report
Dec 21, 2020

Major Issues Report

8-K - Current report
Nov 06, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2020

Major Issues Report

8-K - Current report
Oct 02, 2020

Major Issues Report

8-K - Current report